FDA Approved: TRYVIO — Supplemental Application (Idorsia Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for TRYVIO (aprocitentan) from Idorsia Pharmaceuticals, updating the labeling for its approved use in resistant hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• TRYVIO (APROCITENTAN)

Snippet

SUPPL AP for TRYVIO (APROCITENTAN)